Clinical Trial Update: Study of S1B-408 in Women With Orgasmic Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 study of S1B-408 in women with female orgasmic disorder is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Orgasmic Disorder

Drugs mentioned

• S1B-408

Snippet

Sponsor: S1 Biopharma, Inc. | Conditions: Orgasmic Disorder | Phase 2 | Status: NOT_YET_RECRUITING